Back to search results

Understanding Well-Being in Melanoma Patients During COVID-19

This observational study aims to understand how the COVID-19 pandemic has affected the well-being and health-related quality of life (HRQoL) of people with melanoma. Researchers are using a survey to learn about your experiences during the pandemic, including any psychological distress (like fear or anxiety), and disruptions to your healthcare, finances, and social life. The study also looks at factors like social support and how you cope with stress, to see if these help protect against negative impacts. You can join if you previously participated in study PA15-0336, have an active email, and are alive according to cancer records. The study is currently unclear on its recruitment status and plans to enroll 1152 participants.

Study design
This is an observational study, meaning participants will not receive any specific treatment, but will complete a survey. The study aims to enroll 1152 participants.
What's involved
You would complete a 10-minute questionnaire (survey administration).
Compensation
Not stated in the trial record.
Follow-up
Your experiences and well-being will be measured at the time of survey completion, up to 2 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT04474301

Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic

Recruiting
Not specifiedAll AgesObservational
M.D. Anderson Cancer Center
~1,152 participants
Updated 2026-04-16 on ClinicalTrials.gov
What's tested:Survey Administration

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Experiences during the COVID-19 pandemic
Measured over Survey completion Up to 2 months
+7 more outcomes measured

Conditions

COVID-19 Infection
Melanoma

Explore related trials

Melanoma

Where it's being run

1 sites across 1 states
Texas1

Study leadership

  • Lorenzo Cohen · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center

Who to contact

Lorenzo Cohen
[email protected]
(713) 745-4260
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patients who have signed consent for PA15-0336
Has an active email address and can be contacted via MyChart
Documentation of being alive per the cancer registry

What this trial measures

  • Experiences during the COVID-19 pandemicSurvey completion Up to 2 months

    Including exposure, risk factors, testing, isolation, seropositivity, hospitalization, or loss of family or friends.

  • COVID-19-specific psychological distressSurvey completion Up to 2 months
  • COVID-19-specific healthSurvey completion Up to 2 months
  • COVID-19-specific financial and social disruptionsSurvey completion Up to 2 months
  • COVID-19-specific perceived benefits and social supportSurvey completion Up to 2 months
  • COVID-19-specific health related quality of life (HRQoL)Survey completion Up to 2 months
  • Effects of COVID-19 experiences on COVID-19-specific psychological distress and HRQoLSurvey completion Up to 2 months

    Will evaluate the extent to which resiliency factors such as social support and perceived benefits moderate the effects of COVID-19 experiences on COVID-19-specific psychological distress and HRQoL.

  • Prior lifestyle dataSurvey completion Up to 2 months

    Will explore the association between prior lifestyle data collected as part of PA15-0336 and COVID-19-specific psychological distress and HRQoL.